Todd Dickinson, Ph.D. (Illumina, Inc)

Dr. Dickinson is the Director of Product Marketing for Illumina, Inc. He received a bachelor's degree in chemistry from St. Olaf College and a Ph.D. in analytical chemistry from Tufts University in 1998.

Headquarted in San Diego, California, Illumina's goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Please visit http://www.illumina.com/ for further information.

Hakon Hakonarson, M.D., Ph.D. (Center for Applied Genomics, Children's Hospital of Philadelphia)

Dr. Hakonarson is currently the Director of the Center for Applied Genomics, at Children's Hospital of Philadelphia. His research interest focuses on human genetics, specifically the use of genetic variants and derived biomarkers in clinical medicine.

Dr. Hakonarson is currently working to identify genetic variants that underlie complex medical disorders in children and adults. He and his colleagues are also trying to capture meaningful genetic variants in order to intervene and prevent disease as early as possible and to provide more focused treatment. Please visit http://stokes.chop.edu/directory/?ID=251 for further information.

John Heidelberg, Ph.D. (Department of Biological Sciences, USC)

Dr. Heidelberg is an Associate Professor of Biologcial Sciences at the University of Southern California (USC). He served as the principle investigator on the Vibrio cholerae genome sequencing project, and is currently adding the techniques and approaches of molecular genetics, genomics, and metagenomics to understand life, and its signals and signatures at a new level. Please visit http://www.usc.edu/dept/LAS/biosci/meb/ for further information.

Stephen Wooding, Ph.D. (The McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center)

Dr. Wooding is an Assistant Professor of Human Genetics at the University of Texas Southwestern Medical Center. He received a B.A. in Biology from the University of Colorado, a M.S. in biology from the University of Utah and his Ph.D. in Anthropology from the University of Utah.

Dr. Wooding's research focuses on two main questions: 1) How have population history and natural selection have interacted to produce patterns of genetic variation?, and 2) How can information about population history and natural selection be used in the dissection of genotype-phenotype correlations? Please visit http://www.xmission.com/~wooding/ for further information.

David Magnus, Ph.D. (Stanford School of Medicine)

Dr. Magnus is the Director of the Stanford Center for Biomedical Ethics and an Associate Professor for Stanford School of Medicine.

Dr. Magnus' research interests include genetic testing, gene therapy, genetically engineered organisms, and the history of eugenics. Stem cell research and cloning, and egg procurement. Examining ethical issues in reproductive technologies. Organ transplantation - including donation after cardiac death, ethics of listing decisions. End of life issues in both adults and children. Please visit http://scbe.stanford.edu/profiles/frdActionServlet?choiceId=facProfile&fid=4722 for further information.